ANG Lifesciences India Limited (BOM:540694)

Market Cap	391.75M
Revenue (ttm)	928.47M
Net Income (ttm)	-124.13M
Shares Out	13.06M
EPS (ttm)	-9.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,773
Average Volume	5,321
Open	30.59
Previous Close	30.00
Day's Range	30.50 - 30.60
52-Week Range	21.03 - 62.75
Beta	0.15
RSI	60.47
Earnings Date	May 30, 2025

About ANG Lifesciences India

ANG Lifesciences India Limited manufactures and sells pharmaceuticals products and formulations in India. The company’s products include various therapeutic categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. It offers finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, prefilled syringes, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotio...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 433
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540694

Financial Performance

In 2024, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2023.